Back

Advanced HIV Disease Burden in Selected Health Facilities in Mozambique, October-December 2023

Nguimfack, A.; Filipe, E.; Filimao, D.; Mizela, J.; Bila, E.; Matsinhe, M.; Tomo De Deus, M. I. M.; Gaspar, I.; Ruano, M.; Armando, L.; Tiberi, O. M.

2024-11-28 hiv aids
10.1101/2024.11.26.24317679 medRxiv
Show abstract

IntroductionAdvanced HIV Disease (AHD) is a remaining hurdle in the care and treatment cascade in Mozambique and has the potential to delay Mozambiques progress towards the UNAIDS 95-95-95 goals for 2025. An improved understanding of the prevalence and demographics of AHD is critical to understanding this important condition. MethodsData from October to December 2023 were reviewed from the 79 health facilities implementing the AHD diagnosis and treatment package at the national level. ResultsOverall, 36% (7.811/21.452) of people living with HIV (PLHIV) newly initiated or reinitiated on treatment had a CD4 test, of which 1.986 were diagnosed with AHD. Most diagnosed cases were in the newly initiated PLHIV (1.814) versus reinitiated (179). ConclusionLow CD4 testing uptake means that AHD remains a serious challenge in Mozambiques path towards the elimination of HIV as a public health threat.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.